Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Bavarian Nordic A/S
  6. News
  7. Summary
    BAVA   DK0015998017

BAVARIAN NORDIC A/S

(BAVA)
  Report
Real-time Estimate Cboe Europe  -  04:42 2022-09-27 am EDT
227.85 DKK   +0.15%
09/26UK Government To Offer Second Doses Of Bavarian Nordic's Monkeypox Vaccine To People At Highest Risk
MT
09/20Luc Debruyne Appointed as Observer to the Board of Directors of Bavarian Nordic
GL
09/20Luc Debruyne Appointed as Observer to the Board of Directors of Bavarian Nordic
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Monkeypox Vaccine Maker Bavarian Nordic Voices Concerns On U.S. Dose-Splitting Plan - WAPO

08/10/2022 | 09:07pm EDT

Aug 10 (Reuters) -

* MONKEYPOX VACCINE MAKER BAVARIAN NORDIC VOICES CONCERNS ON U.S. DOSE-SPLITTING PLAN - WAPO

* BAVARIAN NORDIC HAD CONCERNS ABOUT THE SAFETY OF THE NEW METHOD FOR INJECTING MONKEYPOX VACCINE THAT U.S. HEALTH OFFICIALS HAD ADOPTED - WAPO Source text: [https://wapo.st/3QDtbqv] Further company coverage:


© Reuters 2022
All news about BAVARIAN NORDIC A/S
09/26UK Government To Offer Second Doses Of Bavarian Nordic's Monkeypox Vaccine To People At..
MT
09/20Luc Debruyne Appointed as Observer to the Board of Directors of Bavarian Nordic
GL
09/20Luc Debruyne Appointed as Observer to the Board of Directors of Bavarian Nordic
GL
09/20Bavarian Nordic A/S Appoints Luc Debruyne as Board of Directors
CI
09/20European Midday Briefing: Stocks Struggle; Riksbank Surprises w..
DJ
09/20Bavarian Nordic Wins Updated $434 Million Order For Monkeypox Jab From Canadian Governm..
MT
09/20Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for th..
GL
09/20Bavarian Nordic Receives Ten-Year Contract Amendment Valued Up to USD 434 Million for t..
CI
09/20BAVARIAN NORDIC A/S : Changes in management and corporate officers
CO
09/14Take whatever COVID vaccine you can get, says head of EU drugs watchdog
RE
More news
Analyst Recommendations on BAVARIAN NORDIC A/S
More recommendations
Financials
Sales 2022 3 125 M 405 M 405 M
Net income 2022 -445 M -57,7 M -57,7 M
Net cash 2022 2 153 M 279 M 279 M
P/E ratio 2022 -29,1x
Yield 2022 -
Capitalization 16 050 M 2 081 M 2 081 M
EV / Sales 2022 4,45x
EV / Sales 2023 1,58x
Nbr of Employees 868
Free-Float 99,8%
Chart BAVARIAN NORDIC A/S
Duration : Period :
Bavarian Nordic A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAVARIAN NORDIC A/S
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 227,50 DKK
Average target price 429,86 DKK
Spread / Average Target 88,9%
EPS Revisions
Managers and Directors
Paul Chaplin President & Chief Executive Officer
Henrik Neilsen Juuel Chief Financial Officer & Executive Vice President
Gerardus Wilhelmus van Odijk Chairman
Laurence de Moerlooze Chief Medical Officer & Executive Vice President
Russell Thirsk Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
BAVARIAN NORDIC A/S-15.36%2 081
JOHNSON & JOHNSON-3.14%435 655
ELI LILLY AND COMPANY12.76%292 179
ROCHE HOLDING AG-19.31%253 262
ABBVIE INC.4.29%249 673
PFIZER, INC.-25.35%245 989